Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study

Background: We previously conducted a pilot randomized controlled trial “the MASTER study” and demonstrated that alpha-glucosidase inhibitor miglitol and a dipeptidyl peptidase-4 inhibitor sitagliptin modified postprandial plasma excursions of active glucagon-like peptide-1 (aGLP-1) and active gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Masahiro, Fujita, Hiroki, Yokoyama, Hiroki, Mikada, Atsushi, Horikawa, Yohei, Takahashi, Yuya, Yamada, Yuichiro, Waki, Hironori, Narita, Takuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178987/
https://www.ncbi.nlm.nih.gov/pubmed/37176545
http://dx.doi.org/10.3390/jcm12093104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178987/
https://www.ncbi.nlm.nih.gov/pubmed/37176545
http://dx.doi.org/10.3390/jcm12093104

Ejemplares similares